Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPulmonx Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.42 | -$0.37 | -$0.40 |
| Q2 2025 | 2 | -$0.42 | -$0.38 | -$0.40 |
| Q3 2025 | 2 | -$0.41 | -$0.37 | -$0.39 |
| Q4 2025 | 2 | -$0.42 | -$0.38 | -$0.41 |
| Q1 2026 | 1 | -$0.45 | -$0.41 | -$0.43 |
| Q2 2026 | 1 | -$0.39 | -$0.35 | -$0.37 |
| Q3 2026 | 1 | -$0.39 | -$0.35 | -$0.37 |
| Q4 2026 | 1 | -$0.37 | -$0.33 | -$0.35 |
Pulmonx Corporation Earnings Date And Information
Pulmonx Corporation last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.36 earnings per share for the quarter, topping analysts' consensus estimates of $-0.43 by $0.07. The company had revenue of 20.39 M for the quarter and had revenue of 68.68 M for the year. Pulmonx Corporation has generated $-2 earnings per share over the last year ($-1.6 diluted earnings per share) and currently has a price-to-earnings ratio of -4.26. Pulmonx Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Pulmonx Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/01/2024 | Q3 2024 | -$0.36 | $20.29 M | $20.39 M | ||
| 08/02/2024 | Q2 2024 | -$0.39 | $20.15 M | $20.78 M | ||
| 05/03/2024 | Q1 2024 | -$0.36 | $18.85 M | |||
| 02/27/2024 | Q4 2023 | -$0.36 | $19.28 M | |||
| 11/03/2023 | Q3 2023 | -$0.39 | $16.67 M | $17.67 M | ||
| 08/04/2023 | Q2 2023 | -$0.43 | $15.86 M | $17.19 M | ||
| 05/08/2023 | Q1 2023 | -$0.42 | $14.54 M | |||
| 03/01/2023 | Q4 2022 | -$0.38 | $15.43 M | |||
| 11/08/2022 | Q3 2022 | -$0.37 | $14.93 M | $13.50 M | ||
| 08/08/2022 | Q2 2022 | -$0.40 | $13.77 M | $13.95 M | ||
| 05/09/2022 | Q1 2022 | -$0.43 | $10.79 M | |||
| 03/01/2022 | Q4 2021 | -$0.35 | $13.71 M | |||
| 11/09/2021 | Q3 2021 | -$0.28 | $13.18 M | $13.26 M | ||
| 08/10/2021 | Q2 2021 | -$0.34 | $10.59 M | $12.20 M | ||
| 05/12/2021 | Q1 2021 | -$0.34 | $9.24 M | |||
| 03/15/2021 | Q4 2020 | -$0.27 | $9.83 M | |||
| 11/13/2020 | Q3 2020 | -$0.11 | $7.96 M | $10.61 M | ||
| 06/29/2020 | Q2 2020 | -$0.39 | $3.67 M | |||
| 03/30/2020 | Q1 2020 | -$0.35 | $8.62 M | |||
| 12/30/2019 | Q4 2019 | -$0.23 | $10.35 M |
Pulmonx Corporation Earnings: FAQ's
When is Pulmonx Corporation's earnings date?
Pulmonx Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
Did Pulmonx Corporation beat their earnings estimates last
quarter?
In the previous quarter, Pulmonx Corporation (:LUNG) reported $-0.36 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.43 by $0.07.
How can I listen to Pulmonx Corporation's earnings conference
call?
The conference call for Pulmonx Corporation's latest earnings report can be listened to online.
How can I read Pulmonx Corporation's conference call transcript?
The conference call transcript for Pulmonx Corporation's latest earnings report can be read online.
How much revenue does Pulmonx Corporation generate each year?
Pulmonx Corporation (:LUNG) has a recorded annual revenue of $68.68 M.
How much profit does Pulmonx Corporation generate each year?
Pulmonx Corporation (:LUNG) has a recorded net income of $68.68 M. Pulmonx Corporation has generated $-1.6 earnings per share over the last four quarters.
What is Pulmonx Corporation's price-to-earnings ratio?
Pulmonx Corporation (:LUNG) has a price-to-earnings ratio of -4.26 and price/earnings-to-growth ratio is -2.13.